Analyst Ratings for Summit Therapeutics plc (SMMT)
SMMT Rating Summary
SMMT Price Target Summary
- Highest: $40.00 (Citizens)
- Lowest: $11.90 (Bernstein SocGen Group)
- Average: $27.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$27.29 (+55.6%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$27.29 (+55.6%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | Jefferies | Faisal Khurshid | Upgrade | Buy (Hold) |
25.00 (15.00) |
17.28 (17.54) |
1.5% | Details |
| 8/25/2026 | Bernstein SocGen Group | Jeffrey Walch | Upgrade | Market Perform (Underperform) |
11.90 (9.80) |
13.16 (17.54) |
33.28% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
